- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
38 result(s) found for: Biological psychiatry.
Displaying page 1 of 2.
EudraCT Number: 2019-004255-36 | Sponsor Protocol Number: Cesar | Start Date*: 2020-10-05 |
Sponsor Name:Karolinska Universitetssjukhuset | ||
Full Title: Cesar - an open, randomized controlled phase II study, comparing Naltrexon and Fluoxetin treating Compulsive Sexual Behavior Disorder. | ||
Medical condition: Compulsive Sexual Behavior Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004860-31 | Sponsor Protocol Number: 2.2.20110919 | Start Date*: 2011-10-27 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders | ||
Medical condition: Major Depressive Disorder Anxiety Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001244-15 | Sponsor Protocol Number: D22-P006 | Start Date*: 2023-01-12 |
Sponsor Name:GHU Paris Psychiatrie et Neurosciences | ||
Full Title: Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial - PsyCARE_Trial | ||
Medical condition: early psychosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003850-21 | Sponsor Protocol Number: InflaMed001 | Start Date*: 2022-08-03 |
Sponsor Name:Amsterdam UMC, location VUmc | ||
Full Title: Precision psychiatry: Anti-inflammatory medication in Immuno-metabolic depression | ||
Medical condition: Immuno metabolic Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004815-22 | Sponsor Protocol Number: INDICES/WP2/01 | Start Date*: 2012-01-24 | |||||||||||
Sponsor Name:Research Institute of Biological Psychiatry Sct. Hans | |||||||||||||
Full Title: Individualised drug therapy based on pharmacogenomics: focus on carboxylesterase 1 (CES1) | |||||||||||||
Medical condition: Healthy volunteers with special genotypes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003042-47 | Sponsor Protocol Number: InsulaTOP | Start Date*: 2015-12-16 | |||||||||||
Sponsor Name:Centre Hospitalier Henri Laborit | |||||||||||||
Full Title: Psycho-biological substrates of therapeutic benefit of thermal cure on Generalized Anxiety Disorders | |||||||||||||
Medical condition: Generalised Anxiety Disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003128-19 | Sponsor Protocol Number: BiCS2019 | Start Date*: 2019-11-27 | |||||||||||
Sponsor Name:Psykiatrisk Center Glostrup | |||||||||||||
Full Title: Biomarkers in Clozapine-responding Schizophrenia | |||||||||||||
Medical condition: schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003413-26 | Sponsor Protocol Number: MINDEP | Start Date*: 2015-12-14 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Understanding the molecular basis for the use of adjunctive anti-inflammatory treatment in treatment resistant depression: a stratified, randomised, placebo-controlled, experimental medicine study ... | |||||||||||||
Medical condition: Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004764-18 | Sponsor Protocol Number: 01-17 | Start Date*: 2017-07-24 |
Sponsor Name:St Patrick’s Mental Health Services | ||
Full Title: Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022307-22 | Sponsor Protocol Number: BergenPsychosisProject2 | Start Date*: 2011-04-14 | |||||||||||
Sponsor Name:Haukeland University Hospital, Division of Psychiatry | |||||||||||||
Full Title: The Bergen Psychosis Project 2 | |||||||||||||
Medical condition: Patients with schizophrenia and related non-affective psychotic disorders, corresponding to ICD-10 diagnoses F10.5-19.5, and F20-29. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001966-40 | Sponsor Protocol Number: CD001 | Start Date*: 2014-01-27 | ||||||||||||||||
Sponsor Name:Companion Diagnostics BV | ||||||||||||||||||
Full Title: A double blind, randomized, placebo controlled, cross-over, Lybridos dose finding study to validate the predictive power of the diagnostic model for Lybrido and Lybridos efficacy and to identify an... | ||||||||||||||||||
Medical condition: Hypoactive Sexual Desire Disorder/SSRI-induced sexual dysfunction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000445-39 | Sponsor Protocol Number: ACI-24-1801 | Start Date*: 2018-06-19 | |||||||||||
Sponsor Name:AC Immune SA | |||||||||||||
Full Title: A Phase II Double-Blind, Randomized, Placebo-Controlled, Adaptive Design Study to Assess the Safety, Tolerability, Immunogenicity and Target Engagement of ACI-24 Formulations in Patients with Mild ... | |||||||||||||
Medical condition: Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000357-41 | Sponsor Protocol Number: APC040 | Start Date*: 2013-08-28 |
Sponsor Name:The Alimentary Pharmabiotic Centre, University College Cork | ||
Full Title: Identification of the Microbiota Dependent Response to Rifaximin in Irritable Bowel Syndrome Patients | ||
Medical condition: Irritable Bowel Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-004483-22 | Sponsor Protocol Number: 35664 | Start Date*: 2013-11-29 | |||||||||||
Sponsor Name:Mental Health Service, Esbjerg | |||||||||||||
Full Title: NACOS - The effect of N-acetylcystein for depressive symptoms in patients with bipolar depression - A double blind randomized placebo-controlled trial with follow up | |||||||||||||
Medical condition: Bipolar depression | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003733-15 | Sponsor Protocol Number: B-003 | Start Date*: 2013-11-13 |
Sponsor Name:VU University medical center | ||
Full Title: The Dutch CSF and PET Biomarker Concordance of Alzheimer’s Disease pathology study | ||
Medical condition: Patients visiting the VUmc Alzheimer Center with objective cognitive complaints or diagnosed with Alzheimer's Disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004984-11 | Sponsor Protocol Number: P150962J | Start Date*: 2018-07-06 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: "Study of maintenance of the efficacy and adverse effects of pharmacological treatments in sex offenders with paraphilia" ESPARA | |||||||||||||
Medical condition: Sexual offenders with paraphilia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015165-31 | Sponsor Protocol Number: EME-08/43/39 | Start Date*: 2010-07-16 |
Sponsor Name:Northumberland, Tyne and Wear NHS Foundation Trust | ||
Full Title: Antiglucocorticoid augmentation of antiDepressants in Depression: a double-blind, randomised, placebo-controlled, parallel-group trial | ||
Medical condition: depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000361-36 | Sponsor Protocol Number: 12/0278 | Start Date*: 2013-11-12 | |||||||||||
Sponsor Name:Joint Research Office | |||||||||||||
Full Title: A phase IIa/b, randomised, double-blind, placebo-controlled, single-site, parallel group clinical trial to examine cannabidiol (CBD) as a pharmacological treatment for cannabis dependence in a youn... | |||||||||||||
Medical condition: 'Moderate cannabis use disorder' as defined by the diagnostic criteria in DSM-5 (published in May 2013), similar to the previous term 'cannabis dependence' (DSM-4). | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004823-66 | Sponsor Protocol Number: ELTCAN1 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Early-life stress, the endocannabinoid system, and fear memory extinction | |||||||||||||
Medical condition: healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002020-37 | Sponsor Protocol Number: 20/15 | Start Date*: 2015-09-03 | |||||||||||
Sponsor Name:St Patrick's Mental Health Services | |||||||||||||
Full Title: Ketamine for relapse prevention in recurrent depressive disorder: a randomised, controlled pilot trial | |||||||||||||
Medical condition: Recurrent depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
